Events & Presentations

?>
Feb 2020

The 2020 ASCRS Annual Meeting (June 6 -10, 2020)

PolyPid’s abstract "Local Constant Prolonged Release of an Antibiotic for the Prevention of Surgical Site Infections (SSI) Post Colorectal Resection Abdominal Surgeries" was accepted for quick Shot Presentation during ASCRS’ Annual Scientific Meeting. Due to the COVID-19 pandemic the personal meeting was cancelled, however, PolyPid's slides and voice narration, presented by Dr. Anthony Senagore, will remain posted on the ASCRS virtual meeting website from July 27th until the 2021 ASCRS Annual Scientific Meeting in April.

Dec 2019

J.P. Morgan 38th Annual Healthcare Conference (January 13 – 16, 2020)

PolyPid's senior management will attend the J.P. Morgan 38th Annual Healthcare Conference, to be held on January 13 - 16, 2020 in San Francisco, California, USA.

Aug 2019

The 2019 OTA Annual Meeting (September 25-28, 2019)

PolyPid’s abstract "Improved healing of severe open long bone fractures treated with antibiotic-formulated bone graft during the first surgical intervention post-injury" was accepted for Oral presentation at the 2019 OTA Annual Meeting, to be held in Colorado, Denver, on September 25-28, 2019. The Oral Free Paper will be presented by Prof. Doron Norman, in Paper Session II: Tibia and Knee/Tibial Plateau, on Fri., 9/27/19 at 10:16 AM - 10:22 AM.  

Aug 2018

The 2018 Greater New York Dental Meeting (November 25 – 28, 2018)

PolyPid will present its product candidate D-PLEX intended to treat peri-implantitis,  in booth no. 413 at the Israeli pavilion, in the Greater New York Dental Meeting, to be held on November 25th - 28th 2018, in the Jacob K. Javits Convention Center, 11th Ave B/W 34th & 39th Street, David Intercontinental hotel, New York.

Aug 2018

The 39th SICOT Orthopedic World Congress (October 10-13, 2018)

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 39th SICOT Orthopaedic World Congress, to be held in Montreal, Canada, from 10-13 October 2018. The Oral Free Paper will be presented by Dr. Noam Emanuel, PolyPid’s CTO, as a part of the Trauma Free Papers (Pelvis/Lower Limb) session, currently due to take place on 10/12/2018 at 16:00 - 17:30 in Room 517d.

Jul 2018

The 11th Meeting of the Israeli Chapter of the Controlled Release Society (ICRS), (October 7-9, 2018)

PolyPid’s abstract “PLEX technology - A lipid-and-polymer-based novel local drug delivery system - from concept to clinical practice” was accepted for Oral presentation at the 11th meeting of the ICRS, to be held on October 7-9, 2018, at the Hacienda Forest View Hotel, Ma'alot Tarshiha. The presentation is scheduled for Sunday, October 7, 2018 from 15:20 until 15:35  in the session entitled:  INNOVATIVE BIO-INSPIRED AND BIOMIMETIC MATERIALS.

May 2018

Israel’s 17th National Life Sciences & Technology Week (May 15 – 17, 2018)

PolyPid will participate at IATI BioMed (Biomed Israel 2018), Israel’s 17th National Life Sciences & technology Week, to be held May 15 - 17, 2018, at the Tel Aviv Convention Center, Israel. The company will be also presenting at the Start Up Pavilion by Israel Innovation Authority, on May 16 (Booth SP16).

Jan 2018

9th Global Drug Delivery & Formulation – DDF Summit (March 12-14 2018)

PolyPid will participate at the DDF Summit Meeting, to be held in Berlin, Germany.  PolyPid will be represented by Dr. Tamar Alon, PolyPid’s Chief Business Officer. PolyPid will be exploring new collaborations around its revolutionary PLEX™ localized, controlled and prolonged drug delivery platform and products.

Jan 2018

Drug Delivery Partnerships – DDP Meeting (January 22-24, 2018)

PolyPid will participate at the DDP meeting,  to be held in PGA National Resort & Spa, Palm Beach Gardens, FL, US. PolyPid’s poster entitled: “PLEX™ Revolutionizing Medicine by Enabling Localized Controlled and Prolonged Therapeutics” will be presented in the Poster Exhibit Hall. PolyPid will be represented by Dr. Tamar Alon, PolyPid’s Chief Business Officer. PolyPid will be exploring new collaborations around its core PLEX™ local drug delivery platform and products.

Dec 2017

J.P. Morgan 36th Annual Healthcare Conference (January 8 – 11, 2018)

PolyPid's senior management will attend the J.P. Morgan 36th Annual Healthcare Conference, to be held on January 8 - 11, 2018 in San Francisco, California, USA.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >

D-PLEX100

Is designed to prevent the risk of surgical site infections in both bone and soft tissue through its cutting-edge, local, extended-release mechanism

Read More >

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >